CHE · earnings call history
Chemed Q2 FY26 — VITAS Outperforms, Roto-Rooter Navigates Marketing Headwinds
Read the briefChemed Q4 FY25 — VITAS Medicare Cap mitigated, Roto-Rooter faces billing and lead generation challenges
Read the briefBrowse all US companies on the earnings-call register.